Clinical Trial Detail

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT01798485
Title	A Phase 3 Study of Ganetespib in Combination With Docetaxel Versus Docetaxel Alone in Patients With Advanced NSCLC
Acronym	Galaxy 2
Recruitment	Terminated
Gender	both
Phase	Phase III
Variant Requirements	Yes
Sponsors	Synta Pharmaceuticals Corp.
Indications	lung non-small cell carcinoma
Therapies	Ganetespib Docetaxel
Age Groups:	adult
Covered Countries	USA \| SVN \| ROU \| POL \| NLD \| ITA \| HUN \| HRV \| GBR \| FRA \| ESP \| DEU \| CAN \| BEL \| AUT